Related references
Note: Only part of the references are listed.Corticosteroid Pulse Combination Therapy for Refractory Kawasaki Disease: A Randomized Trial
Shohei Ogata et al.
PEDIATRICS (2012)
Importance of C-Reactive Protein Level in Predicting Non-Response to Additional Intravenous Immunoglobulin Treatment in Children with Kawasaki Disease A Retrospective Study
Satoru Iwashima et al.
CLINICAL DRUG INVESTIGATION (2011)
Prediction of the Risk of Coronary Arterial Lesions in Kawasaki Disease by Brain Natriuretic Peptide
Kazunari Kaneko et al.
PEDIATRIC CARDIOLOGY (2011)
Epidemiological features of Kawasaki disease in Korea, 2006-2008
Yong Won Park et al.
PEDIATRICS INTERNATIONAL (2011)
Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease
Ho-Chang Kuo et al.
ACTA PAEDIATRICA (2010)
Natriuretic Peptide as an Adjunctive Diagnostic Test in the Acute Phase of Kawasaki Disease
Nagib Dahdah et al.
PEDIATRIC CARDIOLOGY (2009)
Risk Stratification in the Decision to Include Prednisolone With Intravenous Immunoglobulin in Primary Therapy of Kawasaki Disease
Tohru Kobayashi et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Infliximab Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease
Jane C. Burns et al.
JOURNAL OF PEDIATRICS (2008)
Resistance to intravenous immunoglobulin in children with Kawasaki disease
Adriana H. Tremoulet et al.
JOURNAL OF PEDIATRICS (2008)
Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment
Tetsuya Sano et al.
EUROPEAN JOURNAL OF PEDIATRICS (2007)
Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
Kimiyasu Egami et al.
JOURNAL OF PEDIATRICS (2006)
Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease
Tohru Kobayashi et al.
CIRCULATION (2006)
Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease
H Muta et al.
ACTA PAEDIATRICA (2006)
Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease
S Kurotobi et al.
PEDIATRIC CARDIOLOGY (2005)
Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)
M Ayusawa et al.
PEDIATRICS INTERNATIONAL (2005)
Use of NT-proBNP in routine testing and comparison to BNP
R Pfister et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease
Y Nakamura et al.
PEDIATRICS INTERNATIONAL (2004)
Immunoglobulin failure and retreatment in Kawasaki disease
K Durongpisitkul et al.
PEDIATRIC CARDIOLOGY (2003)
Brain natriuretic peptide can be a useful biochemical marker for myocarditis in patients with Kawasaki disease
T Kawamura et al.
CARDIOLOGY IN THE YOUNG (2002)
Prediction of non-responsiveness to intravenous high-dose γ-globulin therapy in patients with Kawasaki disease at onset
M Fukunishi et al.
JOURNAL OF PEDIATRICS (2000)
Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease
T Kawamura et al.
PEDIATRICS INTERNATIONAL (2000)